Business
Inogen Announces the Appointment of Vafa Jamali to Board of Directors
BEVERLY, Mass., April 06, 2026--Inogen Announces the Appointment of Vafa Jamali to Board of Directors
About this update from Zimmer Biomet Holdings, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1296,"height":446,"url":"https://media.zenfs.com/en/business-wire.com/3f5a3cc17771756ada90cf7ea8bb0380"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Klj3U0kaAawqfJqyKTDD_g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMzMA--/https://media.zenfs.com/en/business-wire.com/3f5a3cc17771756ada90cf7ea8bb0380","width":960,"height":330},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/kSmyeXE_Uv0yF1Qb2FGIpg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04MjY-/https://media.zenfs.com/en/business-wire.com/3f5a3cc17771756ada90cf7ea8bb0380","width":1200,"height":413}},"lazy":false},{"type":"text","content":"BEVERLY, Mass., April 06, 2026--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Vafa Jamali as an independent director to the Inogen Board of Directors (the "Board"), effective on the date of the Company’s 2026 Annual Meeting, or June 15th if earlier.","length":397,"tagName":"p"},{"type":"text","content":"Mr. Jamali is a long-time medical device executive who will bring added depth and expertise to the Board. During his tenure as the Chief Executive Officer of ZimVie, he led the company’s Nasdaq listing following the spin-out from Zimmer Biomet and helped each of the businesses (Spine and Dental) through significant portfolio optimization actions to support a turnaround to higher growth and profitability. Prior to ZimVie, most notably, he spent nearly twelve years at Covidien and Medtronic, where he most recently served as Senior Vice President and President of the Respiratory, Gastrointestinal & Informatics division, a $3 billion business that included 10,000 team members across four businesses and 14 manufacturing sites. While leading that division, he played a key role in accelerating growth and expanding margins.","length":831,"tagName":"p"},{"type":"text","content":""We are pleased to welcome Vafa to the Board and look forward to benefiting from his unique perspectives," said Beth Mora, Chairperson of the Board. "Throughout his many years of leading medical device companies, Vafa has established a track record of driving strategic execution and deliver...